Using Cu as the electrode when the solvent is a 1:1 mix of DMI and HMPA, the conversion rate of 7-ketocholic acid (could reach 98%, the yield of ursodeoxycholic acid was up to 80%. Under the same conditions, linear voltammetry was performed on the electrochemical workstation to study ...
The effects of four different doses of ursodeoxycholic acid (250, 500, 750, and 1000 mg daily) on biliary lipids were studied in 24 patients with radiolucent gallbladder stones. There was a significant increase in the proportion of ursodeoxycholic acid in bile after all doses, being greatest ...
The article discusses a study on whether or not ursodeoxycholic acid reduces itching in intrahepatic cholestasis of pregnancy, and the effect of early term... L.,C.,Chappell,... - BMJ 被引量: 194发表: 2012年 Ursodeoxycholic acid for the treatment of intrahepatic cholestasis of pregnancy Objecti...
Study of human isoursodeoxycholic acid metabolism: Depts. of Internal Medicine III & ∗Organic Chemistry, Aachen University of Technology, Aachen, Germany, and ∗∗Dept. of Biochem. Biophysics, Karolinska Institut, Stockholm, SwedenShow moreShow less...
Despite this lack of evidence about 4,500 pregnant women are treated with ursodeoxycholic acid each year in the UK and many more worldwide. Delivery around 37–38 weeks is also widely practiced in the management of obstetric cholestasis on the assumption that it might pre-empt stillbirths [23...
Despite this lack of evidence about 4,500 pregnant women are treated with ursodeoxycholic acid each year in the UK and many more worldwide. Delivery around 37–38 weeks is also widely practiced in the management of obstetric cholestasis on the assumption that it might pre-empt stillbirths [23...
Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis. BACKGROUND: Ursodeoxycholic acid (UDCA) is the only approved treatment for primary biliary cirrhosis, but its effect on disease progression and survival is... J Goulis,G Leandro,AK Burroughs ...
The effect of six drugs (amantadine, glycyrrhizin, ribavirin, ursodeoxycholic acid, alcohol, and IFN) on HAV RNA translation from the HAV internal ribosoma... T Kanda,O Yokosuka,F Imazeki,... - 《Biochemical & Biophysical Research Communications》 被引量: 54发表: 2005年 Glycyrrhizin ameliorates...
ULTRA Pain Study - Ursodeoxycholic acid in Low Phospholipid Associated Cholelithiasis (LPAC) Treating Recurrent Abdominal Pain Study,Melbourne Health,Interventional,Phase 3
Differences in the effects of chenodeoxycholic and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones. Gastroenterology. 1984 Jul; 87 (1):136–143.Von Bergmann K, Epple-Gutsfeld M, Leiss O. Differences in the effects of chenodeoxycholic and ursodeox...